PMID- 29622599
OWN - NLM
STAT- MEDLINE
DCOM- 20190212
LR  - 20190215
IS  - 1468-201X (Electronic)
IS  - 1355-6037 (Linking)
VI  - 104
IP  - 18
DP  - 2018 Sep
TI  - Why and how to screen for atrial fibrillation.
PG  - 1474-1475
LID - 10.1136/heartjnl-2018-313085 [doi]
FAU - Bisson, Arnaud
AU  - Bisson A
AD  - Service de Cardiologie, Centre Hospitalier Universitaire Trousseau et Faculte de 
      Medecine, Universite Francois Rabelais, Tours 37044, France.
FAU - Bodin, Alexandre
AU  - Bodin A
AD  - Service de Cardiologie, Centre Hospitalier Universitaire Trousseau et Faculte de 
      Medecine, Universite Francois Rabelais, Tours 37044, France.
FAU - Fauchier, Laurent
AU  - Fauchier L
AD  - Service de Cardiologie, Centre Hospitalier Universitaire Trousseau et Faculte de 
      Medecine, Universite Francois Rabelais, Tours 37044, France.
LA  - eng
PT  - Editorial
PT  - Comment
DEP - 20180405
PL  - England
TA  - Heart
JT  - Heart (British Cardiac Society)
JID - 9602087
RN  - 0 (Anticoagulants)
SB  - AIM
SB  - IM
CON - Heart. 2018 Sep;104(18):1492-1499. PMID: 29593077
MH  - Anticoagulants
MH  - *Atrial Fibrillation
MH  - Humans
MH  - Mass Screening
MH  - *Stroke
OTO - NOTNLM
OT  - *atrial fibrillation
OT  - *stroke
COIS- Competing interests: LF has served as a consultant or speaker for Bayer,
      BMS/Pfizer, Boehringer Ingelheim, Livanova, Medtronic and Novartis.
EDAT- 2018/04/07 06:00
MHDA- 2019/02/13 06:00
CRDT- 2018/04/07 06:00
PHST- 2018/04/07 06:00 [pubmed]
PHST- 2019/02/13 06:00 [medline]
PHST- 2018/04/07 06:00 [entrez]
AID - heartjnl-2018-313085 [pii]
AID - 10.1136/heartjnl-2018-313085 [doi]
PST - ppublish
SO  - Heart. 2018 Sep;104(18):1474-1475. doi: 10.1136/heartjnl-2018-313085. Epub 2018
      Apr 5.